CTOs on the Move

Mada Medical Products

www.madamedical.com

 
Mada is a manufacturer of several hundred Medical, Dental, Podiatric and Veterinary products catering to the Home Healthcare and Institutional markets. Mada was incorporated in 1969, with Production and Corporate Offices located in Carlstadt, New Jersey
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Burke County Hospital Auxiliary, Inc

Burke County Hospital Auxiliary, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Waynesboro, GA. To find more information about Burke County Hospital Auxiliary, Inc, please visit www.burkemedical.net

Baker Eye Institute

Baker Eye Institute is a Clinton, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oral Health Products

Oral Health Products is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CME

CME was founded in 1978 by psychiatrist John Schwartz, whose vision was to provide high-quality, practical continuing medical education and information for mental health clinicians throughout the United States. In its first decade, CME successfully

Massive Bio

Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.